Inhibition of human cytochrome P450 enzymes by 1,2-dithiole-3-thione, oltipraz and its derivatives, and sulforaphane

被引:105
作者
Langouët, S
Furge, LL
Kerriguy, N
Nakamura, K
Guillouzo, A
Guengerich, FP
机构
[1] Univ Rennes 1, INSERM, U456, Fac Sci Pharmaceut & Biol, F-35043 Rennes, France
[2] Kalamazoo Coll, Dept Chem, Kalamazoo, MI 49006 USA
[3] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Ctr Mol Toxicol, Sch Med, Nashville, TN 37232 USA
关键词
D O I
10.1021/tx990189w
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Recent studies have demonstrated that two chemoprotective agents, oltipraz (OPZ), a synthetic derivative of the natural compound 1,2-dithiole-3-thione (D3T), and sulforaphane (SF), an isothiocyanate, are not only inducers of glutathione S-transferases but also inhibitors of some major cytochrome P450 enzymes (P450s) involved in xenobiotic metabolism. We examined P450 inhibition by the two compounds and compared two OPZ metabolites (OPZ M-3 and M-8) and D3T using human P450s expressed in Escherichia coli membranes. OPZ was a more potent inhibitor than D3T or SF, in the following order of inhibition: P450 1A2 > 3A4 > 1A1 similar to 1B1 > 2E1. OPZ M3 also inhibited P450s 1A2, 1A1, 1B1, and 3A4 but not more effectively than OPZ. OPZ Mg was not inhibitory. OPZ behaved as a competitive inhibitor of P450 1A2, with a Ki of 1.5 mu M Incubation of P450 1A2 with OPZ and NADPH led to a first-order loss of the P450 spectrum, and the loss was not blocked by glutathione. No such time-dependent loss of P450 was seen with P450 1A2 and D3T, P450 1A2 and OPZ Ms, P450 1A2 and SF, P450 3A4 and OPZ, P450 3A4 and D3T, P450 2E1 and OPZ, or P450 2E1 and D3T. The time- and concentration-dependent loss of P450 1A2 activity in the presence of OPZ was characterized with a K-i of 9 mu M and a k(inactivation) of 0.19 min(-1). The activation of 2-amino-3,5-dimethylimidazo[4,5-f]quinoline (MeIQ) in an E. coli lac-based mutagenicity tester system containing functional human P450 1A2 was inhibited by OPZ(IC50 < 1 mu M) but not appreciably by 40 mu M D3T. Our results indicate that OPZ is a competitive and mechanism-based inhibitor of P450 1A2, and the extent of this inhibition is significantly greater than that of other chemoprotective chemicals with P450 1A2 or other human P450s.
引用
收藏
页码:245 / 252
页数:8
相关论文
共 51 条
[21]  
KENSLER TW, 1987, CANCER RES, V47, P4271
[22]   POTENT INHIBITION OF AFLATOXIN-INDUCED HEPATIC TUMORIGENESIS BY THE MONOFUNCTIONAL ENZYME INDUCER 1,2-DITHIOLE-3-THIONE [J].
KENSLER, TW ;
GROOPMAN, JD ;
EATON, DL ;
CURPHEY, TJ ;
ROEBUCK, BD .
CARCINOGENESIS, 1992, 13 (01) :95-100
[23]  
LANGOUET S, 1995, CANCER RES, V55, P5574
[24]   Effects of administration of the chemoprotective agent oltipraz on CYP1A and CYP2B in rat liver and rat hepatocytes in culture [J].
Langouet, S ;
Maheo, K ;
Berthou, F ;
Morel, F ;
LagadicGossman, D ;
Glaise, D ;
Coles, B ;
Ketterer, B ;
Guillouzo, A .
CARCINOGENESIS, 1997, 18 (07) :1343-1349
[25]   LIPID PEROXIDATION AND DEGRADATION OF CYTOCHROME-P-450 HEME [J].
LEVIN, W ;
LU, AYH ;
JACOBSON, M ;
KUNTZMAN, R ;
POYER, JL ;
MCCAY, PB .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1973, 158 (02) :842-852
[26]   PROTECTION BY 5-(2-PYRAZINYL)-4-METHYL-1,2-DITHIOL-3-THIONE (OLTIPRAZ) AGAINST THE HEPATOTOXICITY OF AFLATOXIN-B1 IN THE RAT [J].
LIU, YL ;
ROEBUCK, BD ;
YAGER, JD ;
GROOPMAN, JD ;
KENSLER, TW .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1988, 93 (03) :442-451
[27]  
Maheo K, 1997, CANCER RES, V57, P3649
[28]   Identification of dithiolethiones with better chemopreventive properties than oltipraz [J].
Maxuitenko, YY ;
Libby, AH ;
Joyner, HH ;
Curphey, TJ ;
MacMillan, DL ;
Kensler, TW ;
Roebuck, BD .
CARCINOGENESIS, 1998, 19 (09) :1609-1615
[29]   METABOLISM OF OLTIPRAZ AND GLUTATHIONE-REDUCTASE INHIBITION [J].
MOREAU, N ;
MARTENS, T ;
FLEURY, MB ;
LEROY, JP .
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (06) :1299-1305
[30]  
MORSE MA, 1989, CANCER RES, V49, P549